Almirall, S.A. $ALM.MC
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING4
READOUTS ≤12 MONTHS4
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| LAD328 NCT07547813 |
P2 | Recruiting | Hidradenitis Suppurativa | 50 | 2027-02 |
| ADhope 2 NCT06526182 |
P3 | Active, not recruiting | Dermatitis, Atopic; Eczema | 520 | 2027-04-25 (+13 mo) |
| LAD191 NCT07151937 |
P2 | Recruiting | Hidradenitis Suppurativa | 200 | 2027-05-25 |
| LAD603 NCT07311564 |
P2 | Recruiting | Alopecia Areata | 136 | 2027-06-23 |
| ADface NCT07873801 |
P3 | Not yet recruiting | Atopic Dermatitis | 230 | 2028-02 |
| LUMINE NCT07542483 |
P3 | Recruiting | Nummular Eczema | 270 | 2028-08 |